0.6580
-0.0220
(-3.24%)
As of 2:48:27 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-18,378
-18,378
--
-75,723
-80,751
Investing Cash Flow
-36
-36
--
-1,867
-1,100
Financing Cash Flow
29,196
29,196
--
-69
260,668
End Cash Position
57,073
57,073
--
121,947
199,606
Interest Paid Supplemental Data
62
62
--
555
492
Capital Expenditure
-36
-36
--
-1,867
-1,100
Issuance of Capital Stock
6,825
6,825
--
--
261,245
Issuance of Debt
--
--
--
--
975
Repayment of Debt
-3,382
-3,382
--
-85
-1,085
Free Cash Flow
-18,414
-18,414
--
-77,590
-81,851
12/31/2021 - 10/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INAB IN8bio, Inc.
0.1481
-3.01%
SNSE Sensei Biotherapeutics, Inc.
0.3053
-2.46%
MRSN Mersana Therapeutics, Inc.
0.2805
-7.61%
IOBT IO Biotech, Inc.
0.8537
-2.77%
CTMX CytomX Therapeutics, Inc.
0.5004
+0.02%
IMRX Immuneering Corporation
1.2285
-4.77%
RLYB Rallybio Corporation
0.2527
+1.08%
KTTA Pasithea Therapeutics Corp.
1.5100
+39.81%
SPRC SciSparc Ltd.
0.2700
-2.00%
ALXO ALX Oncology Holdings Inc.
0.4792
-7.62%